US Patent 9969794 HA binding agents
Patent 9969794 was granted and assigned to Visterra Inc. on May, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
This disclosure relates to novel peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Karthik Viswanathan0
Sasisekharan Raguram0
Vidya Subramanian0
Zachary Shriver0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09969794 HA binding agents US Patent 9969794 HA binding agents
Infobox
Patent Number
09969794
Patent Number
9969794
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09969794 HA binding agents
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09969794
Date of patent
May 15, 2018
Patent application number
13830367
Date Filed
March 14, 2013
Patent primary examiner
Find more entities like US Patent 9969794 HA binding agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
